OSH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OSH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Oak Street Health's interest expense for the three months ended in Dec. 2022 was $ -1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2022 was $-3 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Oak Street Health's Operating Income for the three months ended in Dec. 2022 was $ -132 Mil. Oak Street Health's Interest Expense for the three months ended in Dec. 2022 was $ -1 Mil. Oak Street Health did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
The historical data trend for Oak Street Health's Interest Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oak Street Health Annual Data | |||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | ||||||
Interest Expense | -3.69 | -5.70 | -8.70 | -2.50 | -2.50 |
Oak Street Health Quarterly Data | |||||||||||||||||
Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | |
Interest Expense | Get a 7-Day Free Trial | -0.70 | -0.60 | -0.50 | - | -1.40 |
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oak Street Health (NYSE:OSH) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Oak Street Health's Interest Expense for the three months ended in Dec. 2022 was $-1 Mil. Its Operating Income for the three months ended in Dec. 2022 was $-132 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2022 was $1,328 Mil.
Oak Street Health's Interest Coverage for the quarter that ended in Dec. 2022 is calculated as
Oak Street Health did not have earnings to cover the interest expense. |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Regina M. Benjamin | director | 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453 |
Geoffrey M Price | director, officer: See Remarks | 30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603 |
Robert Guenthner | officer: Chief Legal Officer | 30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603 |
Timothy M Cook | officer: Chief Financial Officer | 30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603 |
Brian Clem | officer: President, Clinical Operations | 30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603 |
Griffin Myers | director, officer: See Remarks | 30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603 |
Newlight Partners Lp | 10 percent owner | C/O NEWLIGHT PARTNERS LP, 320 PARK AVENUE, NEW YORK NY 10022 |
Michael T Pykosz | director, officer: See Remarks | 30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603 |
General Atlantic, L.p. | 10 percent owner | 55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055 |
General Atlantic (spv) Gp, Llc | 10 percent owner | 55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055 |
Cynthia Hiskes | officer: Chief Human Resources Officer | 30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603 |
Gap Coinvestments V, Llc | 10 percent owner | 55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055 |
Kim Keck | director | 30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603 |
Tamara Jurgenson | officer: Chief Growth Officer | 30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603 |
Newlight Harbour Point Spv Llc | 10 percent owner | C/O NEWLIGHT PARTNERS LP, 320 PARK AVENUE, NEW YORK NY 10022 |
From GuruFocus
By sperokesalga sperokesalga • 02-10-2023
By sperokesalga sperokesalga • 03-23-2023
By PurpleRose PurpleRose • 08-03-2022
By sperokesalga sperokesalga • 02-22-2023
By GuruFocus Research GuruFocus Editor • 01-06-2023
By sperokesalga sperokesalga • 02-23-2023
By Business Wire Business Wire • 08-17-2022
By Business Wire Business Wire • 12-22-2022
By Business Wire Business Wire • 02-07-2023
By PRNewswire PRNewswire • 02-08-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.